[The ABBI system as a possibility for evaluating non-palpable lesions].
For non-palpable lesions detected radiographically alone, lumpectomy after needle-localization is currently performed. Specimen radiography provides an indirect proof of complete excision of the mammographic abnormality. Up to now, intraoperative mammography of the operated breast has not been possible. Digital intraoperative mammography is now possible with the ABBI-system, which will be introduced in this article. In a pilot study, we have investigated, whether it is possible to excise small carcinomas with the ABBI stereotactic biopsy device (maximum diameter 20 mm) without compromising breast conserving therapy. In a prospective study, 69 patients were diagnosed or treated using the ABBI-system. In all 60 patients with a primary lesion, a cylindrical excision was performed. Of these, 11 invasive and 5 intraductal carcinomas were diagnosed. 7 of the invasive and 2 of the intraductal cancers were treated with breast conserving surgery. In 9 cases, an in-breast recurrence was suspected. In 7 of these a cylindrical excision was performed. One invasive and 3 intraductal carcinomas were found and mastectomy was performed in these four patients. In two patients with the suspicion of an in-breast recurrence, the ABBI-system was used to perform a core-needle biopsy. In one patient, the biopsy finding was positive and mastectomy was performed. Patients with lesions close to the chest wall are not suited for the ABBI-system. The postoperative course was uneventful in all cases, the cosmetic result after breast-conserving therapy was very good. The advantages of this new method consist in the reliable stereotactic localization of suspicious lesions and in the fast intraoperative imaging.